mpiresearch.com is a domain that was created on 2000-02-04,making it 24 years ago. It has several subdomains, such as intranet.mpiresearch.com gobeyond.mpiresearch.com , among others.
Description:Acquiring MPI Research will enhance Charles River’s position as a leading global early-stage CRO by strengthening its ability to partner with clients across the drug discovery and development...
Keywords:MPI Research acquisition, MPI...
Discover mpiresearch.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 96.94 KB |
Page Load Time: 0.854938 Seconds |
Website IP Address: 208.89.252.231 |
NextGen Laboratories Appointments appointments.nextgenlabs.com |
CHARLES MURPHY Fort Lauderdale Florida Real Estate for Sale – CHARLES MURPHY charlesmurphy.crrunited.com |
Alcon Completes Acquisition of Aerie Pharmaceuticals | Alcon.com investors.aeriepharma.com |
Completes Plus cpd.completesplus.com |
Rhino Truck Bed Liners St. Charles - Spray on Bed Liners and Bed Liner Applicators St. Charles | Cal mo.st-charles.rhinotruckbedliners.com |
Eureka Blog | Charles River Laboratories. eureka.criver.com |
Charles Hollemeersch \ Blog – Charles Hollemeersch Personal Blog charles.hollemeersch.net |
Blackstone Laboratories Blackstone Laboratories m.blackstone-labs.com |
Charles England Elementary School / Charles England Homepage cee.lexcs.org |
RAYMOND JAMES COMPLETES ACQUISITION OF TRISTATE CAPITAL HOLDINGS, INC. | TriState Capital Holdings investors.tristatecapitalbank.com |
Lake Charles Duplicate Bridge Club Lake Charles LA macarthur.bridge-club.org |
Ferozsons Laboratories Limited – Ferozsons Laboratories Limited staging1.ferozsons-labs.com |
Kensington Capital Acquisition Corp. - Kensington Capital Acquisition Corp. kensingtoncap2021spac.q4web.com |
Charles River Completes the Acquisition of MPI Research http://www.mpiresearch.com/ |
NS mpiresearch.com. 3600 IN NS ns-edi.crl.com. |
TXT mpiresearch.com. 300 IN TXT v=spf1 -all |
SOA mpiresearch.com. 3600 IN SOA ns-wlm.crl.com. hostmaster.crl.com. 202 1800 7200 2419200 900 |
Date: Fri, 07 Feb 2020 04:53:58 GMT |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Set-Cookie: __cfduid=d3ef63556cb0a3aae5765716a1f4b343d1581051237; expires=Sun, 08-Mar-20 04:53:57 GMT; path=/; domain=.www.criver.com; HttpOnly; SameSite=Lax; Secure |
Cache-Control: max-age=86400, public |
X-Drupal-Dynamic-Cache: MISS |
Link: https://www.criver.com/insights/charles-river-completes-acquisition-mpi-research; rel="canonical", https://www.criver.com/insights/charles-river-completes-acquisition-mpi-research; rel="alternate"; hreflang="en", https://www.criver.com/insights/charles-river-completes-acquisition-mpi-research; rel="revision" |
X-UA-Compatible: IE=edge |
Content-language: en |
X-Content-Type-Options: nosniff |
X-Frame-Options: SAMEORIGIN |
Expires: Sun, 19 Nov 1978 05:00:00 GMT |
Last-Modified: Thu, 06 Feb 2020 18:39:40 GMT |
Vary: CF-IPCountry,Accept-Encoding |
X-Generator: Drupal 8 (https://www.drupal.org) |
Strict-Transport-Security: max-age=31536000 |
X-Request-ID: v-0921e578-4910-11ea-8c09-1fd9c80e5e0c |
X-AH-Environment: prod |
Age: 36856 |
Via: varnish |
X-Cache: HIT |
X-Cache-Hits: 125 |
CF-Cache-Status: DYNAMIC |
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" |
Server: cloudflare |
CF-RAY: 5612c35bb9c86ce0-SJC |
Content-Encoding: gzip |
charset="utf-8"/ |
content="Charles River Completes Acquisition of MPI Research" itemprop="acquia_lift:content_title"/ |
content="insight" itemprop="acquia_lift:content_type"/ |
content="node page" itemprop="acquia_lift:page_type"/ |
content="en" itemprop="acquia_lift:context_language"/ |
content="" itemprop="acquia_lift:content_section"/ |
content="" itemprop="acquia_lift:content_keywords"/ |
content="19451" itemprop="acquia_lift:post_id"/ |
content="ab03f7c6-fa62-4279-bfd1-6d001de892f4" itemprop="acquia_lift:content_uuid"/ |
content="1522673372" itemprop="acquia_lift:published_date"/ |
content="" itemprop="acquia_lift:persona"/ |
content="1" itemprop="acquia_lift:engagement_score"/ |
content="CHARLESRIVERLABS" itemprop="acquia_lift:account_id"/ |
content="charlesriver_prod" itemprop="acquia_lift:site_id"/ |
content="" itemprop="acquia_lift:contentOrigin"/ |
content="https://builder.lift.acquia.com" itemprop="acquia_lift:liftAssetsURL"/ |
content="https://us-east-1-decisionapi.lift.acquia.com" itemprop="acquia_lift:liftDecisionAPIURL"/ |
content="https://us-east-1-oauth2.lift.acquia.com/authorize" itemprop="acquia_lift:authEndpoint"/ |
content="auto" itemprop="acquia_lift:bootstrapMode"/ |
content="trusted" itemprop="acquia_lift:contentReplacementMode"/ |
content="Featured Story" itemprop="acquia_lift:event_udf12"/ |
content="Anatomic Pathology,Bioanalytical Services,Biomarkers,Clinical Pathology,Clinical Laboratory Support,Developmental and Reproductive Toxicology,Image Analysis,General Toxicology,Medical Device Pathology,Molecular Biology,Musculoskeletal Pathology,Ocular Pathology,Infusion Toxicology,Specialty Endpoints,Musculoskeletal Toxicology,Neurotoxicology,Ocular Toxicology,DMPK,IND-Enabling Studies,Laboratory Sciences,Pathology Services,Safety Pharmacology,Toxicology Services" itemprop="acquia_lift:event_udf16"/ |
content="Biologic,Medical Device,Pharmaceutical,Veterinary Pharmaceutical" itemprop="acquia_lift:event_udf17"/ |
content="Cardiovascular,Inflammation,Metabolic Disease,Musculoskeletal Disease,Neuroscience,Oncology,Ophthalmology" itemprop="acquia_lift:event_udf26"/ |
content="Charles River Laboratories Completes Acquisition of MPI Research" name="title"/ |
content="Acquiring MPI Research will enhance Charles River’s position as a leading global early-stage CRO by strengthening its ability to partner with clients across the drug discovery and development continuum." name="description"/ |
content="Acquiring MPI Research will enhance Charles River’s position as a leading global early-stage CRO by strengthening its ability to partner with clients across the drug discovery and development continuum." name="abstract"/ |
content="MPI Research acquisition, MPI acquisition" name="keywords"/ |
content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
content="ie=edge, chrome=1" http-equiv="x-ua-compatible"/ |
content="false" http-equiv="ImageToolbar"/ |
Ip Country: United States |
City Name: Methuen |
Latitude: 42.7287 |
Longitude: -71.1834 |
Sorry, you need to enable JavaScript to visit this website. Main navigation Solutions Toggle menu Products & Services Toggle menu Research Models & Services Discovery Services Safety Assessment Laboratory Sciences Biologics Testing Solutions Avian Vaccine Services QC Microbial Solutions Scientific Advisory Services Training, Staffing & Operations Support By Research Phase Toggle menu Basic Research Discovery Preclinical Testing Clinical Development Manufacturing & Commercialization BY Therapeutic Area Toggle menu Cardiovascular Disease Immunology Infectious Disease Inflammation Metabolic Disease Microbiome Research Musculoskeletal Disease Neuroscience Oncology Ophthalmology Rare Disease Renal Disorders Respiratory Disease BY Industry Toggle menu Academic Agrochemical & Biocide Biotech/Pharmaceutical Chemical Compounding Pharmacy Contract Manufacturing Organization Dialysis Government/Foundations Medical Device Nutraceuticals & Dietary Supplements Personal Care & Cosmetics Veterinary Medicine BY Molecule Type Toggle menu Small Molecule Biologic Biosimilar Cellular Therapy Vaccine News & Insights Toggle menu All Insights Toggle menu Eureka Blog Vital Science™ Podcast Featured Stories Media Coverage Resource Library Toggle menu All Resources Toggle menu Catalogs/Price Lists Forms Libraries Patents Podcasts Posters Product/Service Materials Publications Tools Videos Webinars On Demand White Papers Events & Training Toggle menu All Events & Training Toggle menu Seminars & Symposiums Webinars Workshops & Trainings ConferencesToggle menuOverview Toggle menu Our History Our People Our Motivation Our Values Our Capabilities Corporate Citizenship Animals in Research Careers Locations Supplier Information Legal Compliance Policies Utility Menu Careers Investors Portals Eureka Blog Contact 0 items Utility Menu Careers Investors Portals Eureka Blog Contact 0 items Main navigation Solutions Toggle menu Products & Services Toggle menu Research Models & Services Discovery Services Safety Assessment Laboratory Sciences Biologics Testing Solutions Avian Vaccine Services QC Microbial Solutions Scientific Advisory Services Training, Staffing & Operations Support By Research Phase Toggle menu Basic Research Discovery Preclinical Testing Clinical Development Manufacturing & Commercialization BY Therapeutic Area Toggle menu Cardiovascular Disease Immunology Infectious Disease Inflammation Metabolic Disease Microbiome Research Musculoskeletal Disease Neuroscience Oncology Ophthalmology Rare Disease Renal Disorders Respiratory Disease BY Industry Toggle menu Academic Agrochemical & Biocide Biotech/Pharmaceutical Chemical Compounding Pharmacy Contract Manufacturing Organization Dialysis Government/Foundations Medical Device Nutraceuticals & Dietary Supplements Personal Care & Cosmetics Veterinary Medicine BY Molecule Type Toggle menu Small Molecule Biologic Biosimilar Cellular Therapy Vaccine News & Insights Toggle menu All Insights Toggle menu Eureka Blog Vital Science™ Podcast Featured Stories Media Coverage Resource Library Toggle menu All Resources Toggle menu Catalogs/Price Lists Forms Libraries Patents Podcasts Posters Product/Service Materials Publications Tools Videos Webinars On Demand White Papers Events & Training Toggle menu All Events & Training Toggle menu Seminars & Symposiums Webinars Workshops & Trainings ConferencesToggle menuOverview Toggle menu Our History Our People Our Motivation Our Values Our Capabilities Corporate Citizenship Animals in Research Careers Locations Supplier Information Legal Compliance Policies Featured Story Charles River Completes Acquisition of MPI Research Aug. 22 2018 You are here Home Insights Charles River Completes Acquisition of MPI Research INTEGRATION UPDATE : Watch as our leaders discuss the positive impacts on our staff and operations, commercial successes, and the value our enhanced team brings to your programs. View the Videos MPI Research, a premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies worldwide, is now a part of the Charles River’s global network of world-class safety assessment facilities. You can navigate the Charles River website to find your drug development solutions and the unique services that the Mattawan site offers. James C. Foster, Chairman and Chief Executive Officer of Charles River Laboratories, commented, We are pleased to welcome the exceptional team at MPI Research to the Charles River family. The addition of MPI’s scientific expertise, high-quality services, and complementary capabilities will enable us to enhance the support we can provide to clients, as they address the complex challenges of drug discovery and early-stage development. The acquisition of MPI also enhances our ability to achieve our long-term growth goals by building scale to meet current and future demand, and by expanding our biotechnology client base, the fastest-growing market segment.” Stay connected with us through this exciting transition by joining our new mailing list. Sign up to keep in touch with our industry-leading scientists and receive news about the world-class drug development services and support that our expanded team provides. Areas of Expertise MPI offers high-quality services and complementary capabilities including: Ototoxicity testing Abuse and dependence liability testing Surgical services and medical device development Ocular toxicology Infectious disease models for vaccine safety and efficacy studies Molecular imaging and radiochemistry Cell and gene therapy Our expertise and innovation is reflected in our work. Our scientists in Mattawan have presented posters and webinars on many topics. View our Resources Facility Overview Located in Mattawan, Michigan, it is the world’s largest nonclinical facility ( 1M square feet) with dedicated vivarium space (500+ animal rooms), bioanalytical/analytical laboratory space, and 4 surgical suites. The MPI Research portfolio complements Charles River’s services by providing both GLP and non-GLP studies. Download Mattawan, Michigan, Facility At-a-Glance Sheet Our People Behind every patient stands thousands of scientists and researchers working together to develop life-saving treatments. Every day, each of us plays a critical role in making a difference in the quality of people’s lives. Meet the MPI Team Share We Recommend Tool IND Gantt Chart Builder Learn More Tool Test Article Calculator Learn More Our Newsletter Receive the latest news and insights to your inbox. Sign up here Social Menu Footer Menu First Solutions Products & Services By Research Phase By Therapeutic Area By Industry By Molecule Type Footer Menu Second News & Insights All Insights Eureka Blog Vital Science™ Podcast Featured Stories Media Coverage Footer Menu Third Resource Library Catalogs/Price Lists Forms Libraries Patents Podcasts Posters Product/Service Materials Publications Tools Videos Webinars On Demand White Papers Footer Menu Forth Events & Training All Events & Training Seminars & Symposiums Webinars Workshops & Trainings Conferences Footer Menu FifthOur History Our People Our Motivation Our Values Our Capabilities Corporate Citizenship Animals in Research Careers Locations Supplier Information Legal Compliance Policies © 2020 Charles River All rights reserved. Footer Bottom Privacy Policy Terms &...
Domain Name: MPIRESEARCH.COM Registry Domain ID: 19113242_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2024-01-31T06:07:59Z Creation Date: 2000-02-04T23:28:45Z Registry Expiry Date: 2025-02-04T23:28:44Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-EDI.CHARLESRIVERLABS.NET Name Server: NS-WLM.CHARLESRIVERLABS.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:00:22Z <<<